Virtual Event | September 20, 2021

Best Practices For Outsourcing Process Development

Source: Cytiva

Perhaps no outsourcing service better determines your drug program’s ultimate success than process development. But “PD” covers a wide range of specific and timely needs. Particularly if you aren’t a process chemist, can you identify key components for working with CDMOs on this crucial step? 

On September 9th, Outsourced Pharma Live Chief Editor, Louis Garguilo, was joined by a panel of experienced and diverse perspectives - Knut Niss, CTO at Mustang Bio, Kim K. Burson, Head of Quality Assurance and Quality Control at Denali Therapeutics, and Scott Zook, SVP Global Manufacturing at Primmune Therapeutics. 

Check out the On-Demand video below for their advice on implementing PD to provide the best experience for both your company and your service provider.

access the Virtual Event!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online